Clinical Trial Update: Efficacy and Safety Study of Combination Therapy to Treat Uncomplicated Obesity [Phase 2]

View source ↗

Summary

This document reports the completion of a Phase 2 trial evaluating a combination therapy for uncomplicated obesity, with data on efficacy and safety.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity

Snippet

Sponsor: Orexigen Therapeutics, Inc | Conditions: Obesity | Phase 2 | Status: COMPLETED